Anteris Technologies Global Corp. (NASDAQ: AVR) is a Healthcare company (Medical - Devices) with a market capitalization of $519M. The Maz Rating grades it against the other companies in its sector.
Anteris Technologies Global Corp.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $5.32, Anteris Technologies Global Corp. trades at 225.3x sales and 2.3x book value. Over the last twelve months it generated about $2M of revenue and a net loss of $202M. It runs a gross margin of 39.3%, an operating margin of -4880.4% and a net margin of -4637.9%. It shows return on equity of -57.2%, return on invested capital of -46.6% and a free cash flow yield of -18.0%. On the balance sheet: a debt-to-equity ratio of 0.07 and a current ratio of 12.45. Over the past 52 weeks the share price ranged from $3.30 to $11.06, with a beta of 0.73.
Anteris Technologies Global Corp. does not currently pay a dividend.
2 Wall Street analyst ratings cover the stock: 2 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Anteris Technologies Global Corp. (AVR) passes 2 of 5 published Shariah screening standards checked by Maz Vantage: it passes S&P Global and Dow Jones, and fails AAOIFI, MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.02% / 30% · (Cash+Inv) / Mkt Cap (36m) 32.5% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 0.02% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 32.5% / 33% · Receivables / Mkt Cap (36m) 0.03% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 0.02% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 32.5% / 33.33% · Receivables / Mkt Cap (24m) 0.03% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 0.31% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 92.2% / 33.33% · Receivables / Avg Assets (4Q) 0.15% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 0.07% / 33.33% · (Cash+ST Inv) / Total Assets 88.7% / 33.33% · (Cash+Recv) / Total Assets 88.8% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Anteris Technologies Global Corp. (AVR) passes 2 of 5 published Shariah screening standards checked by Maz Vantage: it passes S&P Global and Dow Jones, and fails AAOIFI, MSCI and FTSE.
No. Anteris Technologies Global Corp. is over the AAOIFI limit on (Cash+Inv) / Mkt Cap (36m).
Anteris Technologies Global Corp. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.